Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Pharmaxis Ltd ( (AU:SNT) ) has issued an update.
Syntara Limited has announced a new issuance of 44,028,744 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) on February 20, 2025. This issuance is a part of previously announced transactions and reflects Syntara Limited’s strategic financial maneuvers to enhance its market presence and potentially fortify its capital structure, thus impacting its stakeholders and industry positioning.
More about Pharmaxis Ltd
YTD Price Performance: 7.50%
Average Trading Volume: 5,375,335
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$135.8M
For detailed information about SNT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue